R. Douglas Scott

3.3k total citations · 2 hit papers
48 papers, 2.4k citations indexed

About

R. Douglas Scott is a scholar working on General Health Professions, Infectious Diseases and Epidemiology. According to data from OpenAlex, R. Douglas Scott has authored 48 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in General Health Professions, 12 papers in Infectious Diseases and 11 papers in Epidemiology. Recurrent topics in R. Douglas Scott's work include Antibiotic Use and Resistance (10 papers), Healthcare cost, quality, practices (6 papers) and Nosocomial Infections in ICU (6 papers). R. Douglas Scott is often cited by papers focused on Antibiotic Use and Resistance (10 papers), Healthcare cost, quality, practices (6 papers) and Nosocomial Infections in ICU (6 papers). R. Douglas Scott collaborates with scholars based in United States, Australia and United Kingdom. R. Douglas Scott's co-authors include Ralph L. Cordell, Linda M. Kampe, Robert A. Weinstein, Rebecca R. Roberts, Ibrar Ahmad, S.L. Schabowski, David H. Howard, Bala Hota, Susan D. Foster and Stuart B. Levy and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PEDIATRICS.

In The Last Decade

R. Douglas Scott

44 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Direct medical costs of healthcare-associated infections in U.S. hospitals and the benefits of prevention

2009 575 citations R. Douglas Scott profile →
Hospital and Societal Costs of Antimicrobial‐Resistant Infections in a Chicago Teaching Hospital: Implications for Antibiotic Stewardship

2009 513 citations Rebecca R. Roberts, Bala Hota et al. Clinical Infectious Diseases profile →

Peers

Countries citing papers authored by R. Douglas Scott

Since Specialization

Citations

This map shows the geographic impact of R. Douglas Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Douglas Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Douglas Scott more than expected).

Fields of papers citing papers by R. Douglas Scott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Douglas Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Douglas Scott. The network helps show where R. Douglas Scott may publish in the future.

Co-authorship network of co-authors of R. Douglas Scott

This figure shows the co-authorship network connecting the top 25 collaborators of R. Douglas Scott. A scholar is included among the top collaborators of R. Douglas Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Douglas Scott. R. Douglas Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nationwide demonstration of improved COVID-19 vaccination uptake through behavioural reminders 2025 ·Nature Human Behaviour ·(unknown), (unknown), Lev Tankelevitch, (unknown), (unknown), Natalie Gold, Dale Weston, Rachel Rosen, R. Douglas Scott	0
2	Measuring the Direct Medical Costs of Hospital-Onset Infections Using an Analogy Costing Framework 2024 ·PharmacoEconomics ·R. Douglas Scott, Steven D. Culler, James Baggs, Sujan Reddy, (unknown), Shelley S. Magill, Sophia V. Kazakova, John A. Jernigan, Richard E. Nelson, Robert Rosenman, Philip R. Wandschneider	0
3	Location, location, location: a discrete choice experiment to inform COVID-19 vaccination programme delivery in the UK 2022 ·BMC Public Health ·(unknown), Natalie Gold, (unknown), Dale Weston, Rachel Rosen, R. Douglas Scott, Tim Chadborn, Richard Amlôt, (unknown), (unknown)	10
4	Assessing the social cost and benefits of a national requirement establishing antibiotic stewardship programs to prevent Clostridioides difficile infection in US hospitals 2019 ·Antimicrobial Resistance and Infection Control ·R. Douglas Scott, Rachel B. Slayton, Fernanda C. Lessa, James Baggs, Steven D. Culler, L. Clifford McDonald, John A. Jernigan	8
5	Understanding the Economic Impact of Health Care-Associated Infections: A Cost Perspective Analysis 2019 ·Journal of Infusion Nursing ·R. Douglas Scott, Steven D. Culler, Kimberly J. Rask	28
6	The Cost–Benefit of Federal Investment in Preventing Clostridium difficile Infections through the Use of a Multifaceted Infection Control and Antimicrobial Stewardship Program 2015 ·Infection Control and Hospital Epidemiology ·Rachel B. Slayton, R. Douglas Scott, James Baggs, Fernanda C. Lessa, L. Clifford McDonald, John A. Jernigan	19
7	Medicare Reimbursement Attributable to Catheter-associated Urinary Tract Infection in the Inpatient Setting 2014 ·Medical Care ·Sarah H. Yi, James Baggs, Carolyn V. Gould, R. Douglas Scott, John A. Jernigan	21
8	CDC Central-Line Bloodstream Infection Prevention Efforts Produced Net Benefits Of At Least $640 Million During 1990–2008 2014 ·Health Affairs ·R. Douglas Scott, Ronda L. Sinkowitz‐Cochran, (unknown), James Baggs, Scott Goates, Steven L. Solomon, L. Clifford McDonald, John A. Jernigan	12
9	Learning from the past: young Indigenous people's accounts of blood-borne viral and sexually transmitted infections as resilience narratives 2010 ·Culture Health & Sexuality ·Julie Mooney‐Somers, Anna Olsen, (unknown), R. Douglas Scott, (unknown), John Kaldor, Lisa Maher	21
10	Costs Attributable to Healthcare-Acquired Infection in Hospitalized Adults and a Comparison of Economic Methods 2010 ·Medical Care ·Rebecca R. Roberts, R. Douglas Scott, Bala Hota, Linda M. Kampe, (unknown), S.L. Schabowski, Ibrar Ahmad, (unknown), Ralph L. Cordell, Steven L. Solomon, Reidar Hagtvedt, Robert A. Weinstein	132
11	Enhancing Aboriginal and Torres Strait Islander young people's resilience to blood-borne and sexually transmitted infections: findings from a community-based participatory research project 2009 ·Health Promotion Journal of Australia ·Julie Mooney‐Somers, (unknown), R. Douglas Scott, (unknown), John Kaldor, Lisa Maher	31
12	Characteristics of Patient Care Management Problems Identified in Emergency Department Morbidity and Mortality Investigations During 15 Years 2007 ·Annals of Emergency Medicine ·Karen Cosby, Rebecca Roberts, (unknown), (unknown), Jeffrey Schaider, Scott Sherman, Isam W. Nasr, (unknown), (unknown), S.L. Schabowski, Ibrar Ahmad, R. Douglas Scott	36
13	The Cost of Care for Patients with HIV from the Provider Economic Perspective 2006 ·AIDS Patient Care and STDs ·Rebecca R. Roberts, Linda M. Kampe, (unknown), R. Douglas Scott, Tomas Soto, (unknown), Robert J. Rydman, (unknown), Robert A. Weinstein	20
14	Optimizing Care for African-American HIV-Positive Patients 2003 ·AIDS Patient Care and STDs ·Kimberly Y. Smith, (unknown), (unknown), Joseph Gathe, William Johnson, Wilbert Jordan, Helena Kwakwa, (unknown), (unknown), R. Douglas Scott, Anita Vaughn, (unknown), (unknown)	4
15	The Use of Economic Modeling to Determine the Hospital Costs Associated with Nosocomial Infections 2003 ·Clinical Infectious Diseases ·Rebecca R. Roberts, R. Douglas Scott, Ralph L. Cordell, Steven L. Solomon, Lynn Steele, Linda M. Kampe, William E. Trick, Robert A. Weinstein	93
16	The Global Impact of Drug Resistance 2003 ·Clinical Infectious Diseases ·David H. Howard, R. Douglas Scott, Randall M. Packard, (unknown)	88
17	Vaccinating first-year college students living in dormitories for Meningococcal disease 2002 ·American Journal of Preventive Medicine ·R. Douglas Scott, Martin I. Meltzer, Lonny J. Erickson, Philippe De Wals, Nancy E. Rosenstein	28
18	Reliability of patient self-reporting of INR self-test results to a central database utilizing a computerized interactive voice response system 2002 ·Journal of the American College of Cardiology ·Alan K. Jacobson, R. Douglas Scott, (unknown), (unknown)	0
19	Applying Economic Principles to Health Care 2001 ·SHILAP Revista de lepidopterología ·R. Douglas Scott, Steven L. Solomon, John E. McGowan	1
20	Measuring the Economic Costs of Antimicrobial Resistance in Hospital Settings: Summary of the Centers for Disease Control and Prevention–Emory Workshop 2001 ·Clinical Infectious Diseases ·David H. Howard, Ralph L. Cordell, John E. McGowan, Randall M. Packard, R. Douglas Scott, Steven L. Solomon, (unknown)	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact